Center for Reproduction and Genetics, School of Gusu, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Nanjing Medical University, Suzhou, Jiangsu Province, China.
Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, No. 16 Dingxiang road, Changzhou, Jiangsu Province, China.
J Transl Med. 2022 Aug 2;20(1):345. doi: 10.1186/s12967-022-03555-9.
We and others have previously demonstrated that the size-selection enrichment method could remarkably improve fetal fraction (FF) in the early gestational age (GA, 12-13 weeks), suggesting that 9 or 10 weeks should not be used as a threshold for GA in size-selection noninvasive prenatal screening (NIPS). Here, we assessed whether this method was reliable for detecting fetal chromosomal aneuploidy at the earliest GA (6-8 weeks).
Size-selection NIPS for fetal chromosomal aneuploidy was applied to 208 pregnancy plasma samples (102 male and 106 female fetuses), while the 169 pregnancy samples with male fetuses also underwent standard NIPS. Multivariable linear regression models were used to evaluate the association between fold-change of FF and experimental factors.
The sensitivity of the cell-free DNA (cfDNA) test in detecting aneuploidy was 100% when screened with FF enrichment, whereas the sensitivity of the same patients was only 62.5% (5/8) without FF enrichment. In the 102 pregnancy samples with male fetuses, FF increased from 6.1% to 15.7%, and the median increase in FF was 2.8-fold with enrichment. Moreover, there was a trend toward an increasing success rate of the cfDNA test from 6 to 13 weeks of gestation, especially when the test success rate reached 100% after 7 weeks with FF enrichment. Multivariate linear regression analysis demonstrated that a lower initial FF, shorter cfDNA size, increased body mass index (BMI), and later GA were all independent predictors of a higher fold-change of FF. Compared with ≤ 120 bp cfDNA fragments, the mean fold-change of FF differences was 0.820 for 121-125 bp, 0.229 for 126-130 bp, - 0.154 for 131-135 bp, - 0.525 for 136-140 bp and - 0.934 for > 140 bp (P < 0.0001), suggesting that fold-change of FF significantly decreased with cfDNA fragments > 125 bp. These results were statistically significant after adjusting for confounding factors in the models for fold-change of FF.
The FF enrichment method is a reasonable strategy to detect fetal chromosomal aneuploidy in early pregnancy loss with reduced false negatives and increased test success rate after 7 weeks of GA and should be recommended for patients with early pregnancy loss.
我们和其他人之前已经证明,大小选择富集方法可以显著提高早期妊娠(GA,12-13 周)的胎儿分数(FF),这表明 9 或 10 周不应该作为大小选择非侵入性产前筛查(NIPS)的 GA 阈值。在这里,我们评估了该方法是否可用于检测最早的 GA(6-8 周)的胎儿染色体非整倍性。
对 208 例妊娠血浆样本(102 例男性和 106 例女性胎儿)进行了大小选择的胎儿染色体非整倍性 NIPS,而 169 例具有男性胎儿的妊娠样本也进行了标准 NIPS。使用多变量线性回归模型来评估 FF 变化倍数与实验因素之间的关联。
在进行 FF 富集筛选时,cfDNA 检测检测非整倍体的灵敏度为 100%,而没有 FF 富集的相同患者的灵敏度仅为 62.5%(5/8)。在 102 例具有男性胎儿的妊娠样本中,FF 从 6.1%增加到 15.7%,富集后 FF 的中位数增加了 2.8 倍。此外,cfDNA 检测的成功率从 6 周到 13 周呈上升趋势,尤其是在 7 周后使用 FF 富集时,检测成功率达到 100%。多变量线性回归分析表明,较低的初始 FF、较短的 cfDNA 大小、增加的体重指数(BMI)和较晚的 GA 都是 FF 变化倍数较高的独立预测因子。与 ≤120bp cfDNA 片段相比,121-125bp、126-130bp、131-135bp、136-140bp 和 >140bp 的 FF 差异的平均倍数变化分别为 0.820、0.229、-0.154、-0.525 和-0.934(P<0.0001),这表明随着 cfDNA 片段 >125bp,FF 的倍数变化显着降低。在 FF 倍数变化的模型中调整混杂因素后,这些结果具有统计学意义。
FF 富集方法是一种合理的策略,可用于检测早期妊娠丢失中的胎儿染色体非整倍性,可降低假阴性率并提高 7 周后 GA 的检测成功率,应推荐用于早期妊娠丢失的患者。